Transdisciplinary Research in Energetics and Cancer early career investigator training program: first year results.

Cancer Career development Diet Exercise Mentoring Mortality Obesity Physical activity Recurrence Survival Weight

Journal

Translational behavioral medicine
ISSN: 1613-9860
Titre abrégé: Transl Behav Med
Pays: England
ID NLM: 101554668

Informations de publication

Date de publication:
16 03 2021
Historique:
pubmed: 18 2 2020
medline: 19 8 2021
entrez: 18 2 2020
Statut: ppublish

Résumé

Energy imbalance increases cancer burden by increasing cancer risk and mortality. Training early career investigators on conducting impactful energy balance and cancer research is needed. We developed a Transdisciplinary Research in Energetics and Cancer (TREC) Training Program for early career investigators. This analysis examined program satisfaction, knowledge gained, publications, and awards among Year 1 participants (i.e., fellows). The program consists of an in-person course, followed by 1 year of mentorship. Faculty and fellows completed precourse and postcourse surveys. Following the mentorship period, we surveyed fellows for TREC-related research productivity, including publications and grant funding attributed to the program. Twenty fellows were accepted into the program: 3 basic, 7 clinical, and 10 population scientists. Sixteen fellows were junior faculty and four were postdoctoral fellows. The course included ~50 lectures, small group sessions, and faculty-fellow sessions. 96.7% of attendees rated the course in the highest categories of "good/very good." Knowledge significantly improved in 37 of 39 research competencies (94.8%). In the 18 months following the course, fellows published 25 manuscripts, with 3 published in journals with impact factor ≥10. Nineteen grants were funded to TREC fellows (i.e., 7 National Institutes of Health awards, 2 American Cancer Society [ACS] awards, and 10 foundation/pilot awards), and 7 fellows received career promotions. The program's impact will be defined by the degree to which TREC fellows produce discoveries that could improve the health of populations at risk for and/or surviving cancer. Upon the conclusion of our fifth year in 2021, we will publicly disseminate the program material.

Identifiants

pubmed: 32065834
pii: 5739577
doi: 10.1093/tbm/ibaa009
pmc: PMC7963289
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

549-562

Subventions

Organisme : NCI NIH HHS
ID : P30 CA016359
Pays : United States
Organisme : NCI NIH HHS
ID : R25 CA203650
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000142
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Informations de copyright

© Society of Behavioral Medicine 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Br J Cancer. 2018 Apr;118(7):1013-1019
pubmed: 29527008
Chronobiol Int. 2019 Feb;36(2):203-213
pubmed: 30365354
J Natl Cancer Inst. 2018 Nov 1;110(11):1239-1247
pubmed: 29788487
Epidemiology. 2018 Sep;29(5):604-613
pubmed: 29864084
Breast Cancer Res Treat. 2019 Feb;173(3):545-557
pubmed: 30367332
JAMA. 2016 Jun 7;315(21):2284-91
pubmed: 27272580
J Phys Act Health. 2015 Aug;12(8):1052-60
pubmed: 25271475
Cancer. 2019 Mar 15;125(6):910-920
pubmed: 30500981
Chronobiol Int. 2017;34(8):1042-1056
pubmed: 28650674
Am J Prev Med. 2018 Jan;54(1):144-150
pubmed: 29122356
Cancer Causes Control. 2013 Apr;24(4):695-704
pubmed: 23378138
Breast Cancer Res Treat. 2018 Nov;172(1):105-112
pubmed: 30062572
Curr Oncol Rep. 2018 Apr 30;20(7):50
pubmed: 29713835
Contemp Clin Trials. 2018 Mar;66:9-19
pubmed: 29330081
Transl Behav Med. 2020 May 20;10(2):423-434
pubmed: 30445595
Mol Cancer Res. 2018 May;16(5):869-879
pubmed: 29453319
Sleep. 2017 Dec 1;40(12):
pubmed: 29029250
Front Public Health. 2018 Jul 19;6:191
pubmed: 30073158
J Phys Act Health. 2018 Jan 1;15(1):1-6
pubmed: 28682735
JAMA Oncol. 2019 Feb 1;5(2):155-163
pubmed: 30520976
J Natl Cancer Inst. 2012 Jun 6;104(11):815-40
pubmed: 22570317
Oncotarget. 2018 Jun 29;9(50):29495-29507
pubmed: 30034633
N Engl J Med. 2016 Aug 25;375(8):794-8
pubmed: 27557308
Cancer Prev Res (Phila). 2018 Sep;11(9):545-550
pubmed: 29925515
Clin Transl Sci. 2013 Feb;6(1):26-33
pubmed: 23399086
Support Care Cancer. 2019 Apr;27(4):1435-1441
pubmed: 30225570
J Clin Oncol. 2014 Nov 1;32(31):3568-74
pubmed: 25273035
Breast Cancer Res. 2018 Oct 19;20(1):124
pubmed: 30340503
J Phys Act Health. 2019 Mar 1;16(3):214-221
pubmed: 30798690
Clin Cancer Res. 2016 Apr 1;22(7):1565-71
pubmed: 26792261
Cancer. 2020 Jan 15;126(2):329-336
pubmed: 31568587
J Clin Oncol. 2018 Mar 20;36(9):875-883
pubmed: 29356607
Cancer. 2019 Jul 1;125(13):2262-2271
pubmed: 30840336

Auteurs

Melinda L Irwin (ML)

Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, USA.
Yale Cancer Center, New Haven, CT, USA.

Diana Lowry (D)

Cancer Prevention Program/Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Marian L Neuhouser (ML)

Cancer Prevention Program/Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Jennifer Ligibel (J)

Dana-Farber Cancer Institute, Boston, MA, USA.

Kathryn Schmitz (K)

Division of Health Services and Behavioral Research, Pennsylvania State University, Hershey, PA, USA.

Ruth E Patterson (RE)

Department of Family and Preventive Medicine, Division of Epidemiology, University of California, La Jolla, CA, USA.

Graham Colditz (G)

Division of Public Health Sciences, School of Medicine, Washington University in St. Louis, St. Louis, MO, USA.

Fangyong Li (F)

Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, USA.
Yale Cancer Center, New Haven, CT, USA.

Linda Nebeling (L)

Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH